Beranda › Leukemia Mieloid Akut › New Jersey › Edison
Uji klinis Leukemia Mieloid Akut di Edison, NJ
20 studi untuk Leukemia Mieloid Akut mencari peserta di lokasi sekitar Edison (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
Testing the Anti-cancer Drug, Cirtuvivint, and Its Combination With ASTX727 to Improve Outcomes in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndromes
Menerima pesertaFase 1
- Rutgers Cancer Institute of New Jersey, New Brunswick · 3 mi jauhnya
- Memorial Sloan Kettering Basking Ridge, Basking Ridge · 15 mi jauhnya
Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)
Menerima pesertaFase 2
- Rutgers Cancer Institute of New Jersey, New Brunswick · 3 mi jauhnya
- Memorial Sloan Kettering Basking Ridge, Basking Ridge · 15 mi jauhnya
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
Menerima pesertaFase 2
- Rutgers Cancer Institute of New Jersey, New Brunswick · 3 mi jauhnya
- Memorial Sloan Kettering Basking Ridge, Basking Ridge · 15 mi jauhnya
Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)
Menerima pesertaFase 2
- Rutgers Cancer Institute of New Jersey, New Brunswick · 3 mi jauhnya
- Memorial Sloan Kettering Basking Ridge, Basking Ridge · 15 mi jauhnya
A Study of CRD3874-SI in People With Leukemia
Menerima pesertaFase 1
- Memorial Sloan Kettering at Basking Ridge (All Protocol Activities), Basking Ridge · 15 mi jauhnya
Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)
Menerima pesertaFase 2
- Rutgers Cancer Institute of New Jersey, New Brunswick · 3 mi jauhnya
- Memorial Sloan Kettering Basking Ridge, Basking Ridge · 15 mi jauhnya
Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
Menerima pesertaFase 2
- Rutgers Cancer Institute of New Jersey, New Brunswick · 3 mi jauhnya
- Memorial Sloan Kettering Basking Ridge, Basking Ridge · 15 mi jauhnya
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
Menerima pesertaFase 3
- Saint Peter's University Hospital, New Brunswick · 3 mi jauhnya
- Rutgers Cancer Institute of New Jersey-Robert Wood Johnson University Hospital, New Brunswick · 3 mi jauhnya
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
Menerima pesertaFase 1/2
- Saint Peter's University Hospital, New Brunswick · 3 mi jauhnya
- Rutgers Cancer Institute of New Jersey-Robert Wood Johnson University Hospital, New Brunswick · 3 mi jauhnya
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
Menerima pesertaFase 3
- Rutgers Biomedical and Health Sciences, New Brunswick · 3 mi jauhnya
A Study of the Combination of Ivosidenib, Azacitidine, and Venetoclax Followed by Ivosidenib Alone in People With Acute Myeloid Leukemia
Menerima pesertaFase 2
- Memoral Sloan Kettering at Basking Ridge (Limited Protocol Activities), Basking Ridge · 15 mi jauhnya
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
Menerima pesertaStudi observasional
- Robert Wood Johnson/Cancer Institute of New Jersey, New Brunswick · 3 mi jauhnya
A Study of Gilteritinib in Combination With Ivosidenib or Enasidenib in People With Acute Myeloid Leukemia (AML)
Menerima pesertaFase 1
- Memorial Sloan Kettering Basking Ridge, Basking Ridge · 15 mi jauhnya
A Study of CD371-YSNVZIL-18 CAR T Cells in People With Acute Myeloid Leukemia
Menerima pesertaFase 1
- Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities), Basking Ridge · 15 mi jauhnya
A Study of Revumenib and Mezigdomide in People With Leukemia
Menerima pesertaFase 1/2
- Memorial Sloan Kettering at Basking Ridge (All Protocol Activities), Basking Ridge · 15 mi jauhnya
A Study of Natural Killer Cells in Combination With Atezolizumab in People With Acute Myelogenous Leukemia
Menerima pesertaFase 1
- Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities), Basking Ridge · 15 mi jauhnya
A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
Menerima pesertaFase 1/2
- Rutgers Cancer Institute of New Jersey, New Brunswick · 3 mi jauhnya
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
Menerima pesertaFase 1
- Rutgers Cancer Institute, New Brunswick · 3 mi jauhnya
A Study of ADCLEC.syn1 in People With Acute Myeloid Leukemia
Menerima pesertaFase 1
- Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities), Basking Ridge · 15 mi jauhnya
A Study of Azacitidine and Venetoclax in People With Acute Myeloid Leukemia (AML)
Menerima pesertaFase 2
- Memorial Sloan Kettering at Basking Ridge (All Protocol Activities), Basking Ridge · 15 mi jauhnya
Uji klinis Leukemia Mieloid Akut di kota lain
- Houston, TX85 studi
- New York City, NY51 studi
- Boston, MA44 studi
- Baldwin Park, CA40 studi
- Seattle, WA40 studi
- Columbus, OH35 studi
- Philadelphia, PA34 studi
- Durham, NC33 studi
- Atlanta, GA30 studi
- Tampa, FL29 studi
- Chicago, IL26 studi
- Portland, OR25 studi
Studi lain di Edison
- Kanker Payudara68 studi
- Kanker Paru Non-Sel Kecil47 studi
- Kanker (semua jenis)33 studi
- Kanker Prostat29 studi
- Kanker Kolorektal23 studi
- Kanker Paru23 studi
- Mieloma Multipel22 studi
- Kanker Kandung Kemih21 studi
- Kanker Metastatik20 studi
- Kanker Ovarium20 studi
- Kanker Endometrium19 studi
- Karsinoma Urotelial (Sel Transisional)18 studi
Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.